Article info
PDFPancreas
Original article
Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
- Correspondence to Professor Markus M Lerch, Department of Medicine A, University Medicine Greifswald, Ferdinand-Sauerbruchstrasse, Greifswald 17475, Germany; lerch{at}uni-greifswald.de
Citation
Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis
Publication history
- Received June 14, 2016
- Revised December 22, 2016
- Accepted December 26, 2016
- First published January 20, 2017.
Online issue publication
March 06, 2019
Article Versions
- Previous version (6 March 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/